Company / Total Assets
Processa Pharmaceuticals, Inc. Total Assets History
FY2013-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$8.6M
FY2022
5-year range
$3.2K / $26.5M
FY2018-FY2022
Trend
-67.4%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $3,237 to $9M over the past 6 years.
Based on SEC 10-K filings.
$9M in FY2022.
Improved from $3,237 to $9M over the past 6 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, total assets decreased 67.4% year-over-year.
- Peak total assets was recorded in FY2021.
- Lowest total assets in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $8.6M | -67.4% |
| FY2021 | $26.5M | +817431.8% |
| FY2016 | $3.2K | -96.9% |
| FY2015 | $104.3K | -95.9% |
| FY2014 | $2.5M | -13.5% |
| FY2013 | $2.9M | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026